ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,765Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 973

$628K Total Retail Price of All Prescriptions

Rank: 64 out of 973

420 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,032 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
HYDROCODONE-ACETAMINOPHEN 735 407 S3 1 4
SIMVASTATIN 558 446 2 1
LISINOPRIL 396 286 3 3
OMEPRAZOLE 369 275 4 5
HYDROCHLOROTHIAZIDE 352 308 5 11
FUROSEMIDE 336 256 6 6
LEVOTHYROXINE SODIUM 314 262 7 2
WARFARIN SODIUM 314 313 7 10
AMLODIPINE BESYLATE 309 250 9 7
POTASSIUM CHLORIDE 275 217 10 9
METOPROLOL TARTRATE 265 218 11 13
MELOXICAM 246 184 12 23
GABAPENTIN 201 153 13 12
NAMENDA 194 183 14 31
METFORMIN HCL 185 152 15 8
METOPROLOL SUCCINATE 166 163 16 17
CITALOPRAM HBR 156 117 17 14
ALENDRONATE SODIUM 143 121 18 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 142 118 19 25
ZOLPIDEM TARTRATE 139 97 20 20
DIGOXIN 126 126 21 32
KLOR-CON M20 124 98 22 64
DONEPEZIL HCL 124 101 22 26
LOSARTAN POTASSIUM 114 99 24 19
ATENOLOL 113 90 25 16
BYSTOLIC 111 104 26 110
OXYCODONE-ACETAMINOPHEN 108 75 S2 27 89
AMITRIPTYLINE HCL 107 66 R 28 52
NEXIUM 101 72 29 30
CYMBALTA 99 77 30 40
GLIPIZIDE ER 98 85 31 135
SPIRONOLACTONE 95 68 32 49
TAMSULOSIN HCL 92 84 33 28
LEVOFLOXACIN 89 72 34 84
CLOPIDOGREL 82 74 35 44
GLIPIZIDE 81 74 36 69
SERTRALINE HCL 80 68 37 21
ATORVASTATIN CALCIUM 76 55 38 15
CYCLOBENZAPRINE HCL 74 45 R 39 42
CARVEDILOL 71 48 40 27
ROPINIROLE HCL 70 63 41 72
PLAVIX 70 62 41 78
ALLOPURINOL 70 66 41 29
TRAMADOL HCL 69 37 44 18
CRESTOR 68 55 45 34
LANTUS SOLOSTAR 68 53 45 99
PRAVASTATIN SODIUM 64 64 47 22
TRIAMTERENE-HCTZ 63 54 48 51
DIOVAN 59 56 49 63
TRIAMCINOLONE ACETONIDE 59 50 49 120
PROAIR HFA 58 36 51 54
HUMALOG 58 43 51 127
DOXYCYCLINE HYCLATE 55 46 53 96
PEN NEEDLE 53 41 54 171
OXYCONTIN 53 20 S2 54 126
ALBUTEROL SULFATE 52 52 56 137
ZETIA 52 40 56 81
TRAZODONE HCL 51 36 58 48
FAMOTIDINE 50 38 59 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.